Augmentation with ramelteon to achieve remission in geriatric major depression

Psychiatry and Clinical Neurosciences

Volumn 66, Issue 1, 2012, Pages 81-82

  Furuya, Motohide ^a   Kunishige, Kazuhiko ^a,b   Miyaoka, Tsuyoshi ^a   Wake, Rei ^a   Liaury, Kristian ^a   Sadakuni, Futoshi ^b   Horiguchi, Jun ^a  

^a SHIMANE UNIVERSITY   (Japan)

^b Niho Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BROTIZOLAM; MELATONIN; RAMELTEON; SEROTONIN; SERTRALINE; ZOLPIDEM;

AGED; BEDTIME DOSAGE; CASE REPORT; DAYTIME SOMNOLENCE; DISEASE SEVERITY; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; HAMILTON ANXIETY SCALE; HUMAN; INSOMNIA; LETTER; MAJOR DEPRESSION; MALE; REMISSION; TREATMENT OUTCOME;

AGED; DEPRESSIVE DISORDER, MAJOR; DRUG THERAPY, COMBINATION; HUMANS; INDENES; MALE; RECEPTORS, MELATONIN; SERTRALINE; SLEEP INITIATION AND MAINTENANCE DISORDERS;

EID: 84855995427     PISSN: 13231316     EISSN: 14401819     Source Type: Journal    
DOI: 10.1111/j.1440-1819.2011.02298.x     Document Type: Letter

References (3)

1. Srinivasan V, Pandi-Perumal SR, Trakht I, et al,. Pathophysiology of depression: Role of sleep and the melatonergic system. Psychiatry Res. 2009; 165: 201-214.
2. Turek FW, Gillette MU,. Melatonin, sleep, and circadian rhythm: Rationale for development of specific melatonin agonists. Sleep Med. 2004; 5: 523-532. (Pubitemid 39420030)
3. Pandi-Perumal SR, Srinivasan V, Spence DW, et al,. Ramelteon: A review of its therapeutic potential in sleep disorders. Adv. Ther. 2009; 26: 613-626.